TY - JOUR
T1 - Eighth IQUAM consensus conference position statement
T2 - Transatlantic innovations, April 2009
AU - Neuhann-Lorenz, Constance
AU - Fedeles, Josef
AU - Eisenman-Klein, Marita
AU - Kinney, Brian
AU - Cunningham, Bruce L.
PY - 2011/3
Y1 - 2011/3
N2 - Background: On April 7, 2009, the International Committee for Quality Assurance, Medical Technologies and Devices in Plastic Surgery (IQUAM) issued its 8th Position Statement. IQUAM is a professional medical and scientific organization committed to the surveillance of existing and new technologies and devices in plastic surgery. IQUAM periodically reviews and evaluates updated international literature and studies and scientific data, and recommends standards of treatment for plastic surgery devices and technologies. IQUAM proscribes potentially deleterious use of products, devices, and technologies, or their unintended application or application for unsuitable indications. Methods: Presentations of an international panel of experts made during the Transatlantic Innovations Symposia in Paris, in April of 2009, were reviewed by an advisory board that prepared the position statement for distribution to plastic surgeons and regulatory bodies. The advisory panel was international in nature and included plastic surgeons with expertise in the specific areas evaluated. Results: Three clinical areas of greatest concern to plastic surgeons were evaluated for efficacy and safety: silicone breast implants, tissue engineering, and injectable therapies. Conclusion: Specific recommendations designed to increase clinical safety and patient education for informed consent were made in each area.
AB - Background: On April 7, 2009, the International Committee for Quality Assurance, Medical Technologies and Devices in Plastic Surgery (IQUAM) issued its 8th Position Statement. IQUAM is a professional medical and scientific organization committed to the surveillance of existing and new technologies and devices in plastic surgery. IQUAM periodically reviews and evaluates updated international literature and studies and scientific data, and recommends standards of treatment for plastic surgery devices and technologies. IQUAM proscribes potentially deleterious use of products, devices, and technologies, or their unintended application or application for unsuitable indications. Methods: Presentations of an international panel of experts made during the Transatlantic Innovations Symposia in Paris, in April of 2009, were reviewed by an advisory board that prepared the position statement for distribution to plastic surgeons and regulatory bodies. The advisory panel was international in nature and included plastic surgeons with expertise in the specific areas evaluated. Results: Three clinical areas of greatest concern to plastic surgeons were evaluated for efficacy and safety: silicone breast implants, tissue engineering, and injectable therapies. Conclusion: Specific recommendations designed to increase clinical safety and patient education for informed consent were made in each area.
UR - http://www.scopus.com/inward/record.url?scp=79952773175&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79952773175&partnerID=8YFLogxK
U2 - 10.1097/PRS.0b013e318206312e
DO - 10.1097/PRS.0b013e318206312e
M3 - Article
C2 - 21364439
AN - SCOPUS:79952773175
SN - 0032-1052
VL - 127
SP - 1368
EP - 1375
JO - Plastic and reconstructive surgery
JF - Plastic and reconstructive surgery
IS - 3
ER -